stars 1 stars 2 stars 3

Cathrx is an innovative Australian medical device company engaged in the development of minimally invasive diagnostic and therapeutic electrophysiology catheters, used in the treatment of debilitating, and potentially lethal, cardiac arrhythmias. On the back of our extensive and continually growing patent portfolio, we have developed the world's first range of reposable diagnostic and ablation catheters. The introduction of truly reusable catheter technology will improve the care afforded patients by making prohibitively expensive procedures more accessible, and significantly reduce the environmental footprint of electrophysiology procedures. We believe that our technology platform removes many of the technical limitations associated with conventional single use catheters. With this, we envisage the development of new and exciting next generation technologies to advance the treatment of cardiac arrhythmias.

CathRx Ltd Questions

The CathRx Ltd annual revenue was $5.5 million in 2026.

CathRx Ltd is based in Rydalmere, New South Wales.

The NAICS codes for CathRx Ltd are [339, 33].

The SIC codes for CathRx Ltd are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users